Brief: Australia's ACCC Says Not Satisfied Of Claimed Benefits From Proposed Settlement Between Pharmaceutical Cos

Bristol-Myers Squibb

23/03/2022 01:22

March 23 (Reuters) - ACCC:
    * AUSTRALIA'S ACCC - PROPOSES TO DENY AUTHORISATION FOR
PROVISIONS
OF SETTLEMENT, LICENCE DEAL BETWEEN CELGENE AND GENERIC DRUG
COS, JUNO AND NATCO
    * CELGENE CORP -   CELGENE, JUNO AND NATCO ARE SEEKING
AUTHORISATION TO SETTLE A PATENT DISPUTE CURRENTLY BEFORE
FEDERAL COURT OF AUSTRALIA

Source text for Eikon:  ID: 
Further company coverage:  CELG.S 

 ((Reuters.Briefs@thomsonreuters.com;))